Kuansheng S. Ma - Publications

Long-Term Outcome of No-Touch Radiofrequency Ablation for Treating AFP-Positive Small Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: February 20, 2026

Predictive Value of Age-Adjusted Charlson Comorbidity Index on Survival Outcomes of Hepatocellular Carcinoma Patients with Comorbidities Undergoing Radiofrequency Ablation.

Journal: Journal of hepatocellular carcinoma

Published: January 30, 2026

Short- and Long-Term Outcomes of Radiofrequency Ablation for Early Hepatocellular Carcinoma with Liver Dysfunction.

Journal: Journal of hepatocellular carcinoma

Published: January 01, 2026

Subsegmental radiofrequency ablation: a novel ablation technique based on portal territory for treatment of hepatocellular carcinoma.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: October 20, 2025

Knowledge, Attitudes, and Practices Regarding Hepatitis B and Liver Cancer Among Liver Cancer Patients and Their Families in China.

Journal: Cancer management and research

Published: June 11, 2025

Chronic stress impacts the prognosis of hepatocellular carcinoma patients after curative treatment by establishing a novel comprehensive classification: a cohort study and systematic review.

Journal: BMC psychiatry

Published: December 02, 2024

Solid pseudopapillary neoplasms of the pancreas (SPNs): diagnostic accuracy of CT and CT imaging features.

Journal: World journal of surgical oncology

Published: April 11, 2024

Impact of body composition on the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization: A systematic review and meta-analysis.

Journal: Heliyon

Published: October 18, 2023

Transcriptomic and metabolomic analysis of peri-tumoral hepatic tissue in hepatocellular carcinoma: unveiling the molecular landscape of immune checkpoint therapy resistance.

Journal: Frontiers in pharmacology

Published: September 30, 2023

Regorafenib combined with a PD-1 inhibitor in the second-line setting for unresectable hepatocellular carcinoma in real-world practice.

Journal: Journal of gastrointestinal oncology

Published: July 26, 2023

Unsupervised Machine Learning of MRI Radiomics Features Identifies Two Distinct Subgroups with Different Liver Function Reserve and Risks of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.

Journal: Cancers

Published: April 24, 2023

A radiomics model based on preoperative gadoxetic acid-enhanced magnetic resonance imaging for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: February 13, 2023